1.6 Neuromuscular and Ganglionic Blockers

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/79

flashcard set

Earn XP

Description and Tags

Jackson be fr rn

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

80 Terms

1
New cards

cholinergic agents/ agonists

parasympathomimetics

2
New cards

cholinergic blocking/antagonists

parasympatholytic

3
New cards

adrenergic agent/agonists

sympathomimetic

4
New cards

adrenergic blockers/antagonists

sympatholytic

5
New cards

clinical relevance of neuromuscular and ganglionic blocking agents

muscle relaxation in surgery, facilitation of intubation and ventilation, tx of malignant hyperthermia, nad HTN emergencies

6
New cards

muscle relaxants can either be ____ or _____ acting

peripherally or centrally

7
New cards

explain the presynaptic events in the Neuromuscular junction

Na, K, and Ca currents flow and lead to Ca influx, which leads to vesicle exocytosis and release of Ach into the celf

8
New cards

explain the cleft events in the Neuromuscular junction

ACh diffuses and is either hydrolyzed by AChE or binds to receptors

9
New cards

what does AChE do to ACh

it inactivates our girl via hydrolysis

10
New cards

explain the postsynaptic events in the Neuromuscular junction

ACh binds to Nicotinic M receptors causing Na and K channels to open, leading to depolarization, which leads to an AP, which finally leads to muscle contraction

11
New cards

peripherally acting muscle relaxant subcategories

depolarizing, nondepolarizing, and direct acting

12
New cards

example of a depolarizing peripherally acting muscle relaxant

succinylcholine

13
New cards

classification of succinylcholine

depolarizing peripherally acting muscle relaxant

14
New cards

examples of nondepolarizing peripherally acting muscle relaxant

tubocurarine, pancuronium, vercuronium, rocuronium

15
New cards

classification of tubocurarine, pancuronium, vercuronium, rocuronium

nondepolarizing peripherally acting muscle relaxant

16
New cards

examples of direct acting peripherally acting muscle relaxants

dantrolene and quinine

17
New cards

classification of dantrolene

direct, peripheral acting muscle relaxant

18
New cards

classification of qunine

direct, peripheral acting muscle relaxant

19
New cards

examples of centrally acting muscle relaxants

Chlorzoxazone, Diazepam, Baclofen, Tizanidine, Metaxalone

20
New cards

classification of Chlorzoxazone

centrally acting muscle relaxant

21
New cards

classification of Diazepam

centrally acting muscle relaxant

22
New cards

classification of Baclofen

centrally acting muscle relaxant

23
New cards

classification of Tizanidine

centrally acting muscle relaxant

24
New cards

classification of Metaxalone

centrally acting muscle relaxant

25
New cards

non depolarizing muscle relxants can be further categorized as…

short acting, intermediate acting, and long acting

26
New cards

indications of non-depolarizing neuromuscular blockers (peripherally acting)

adjuvants to surgical anesthesia

intubation

precurarization

27
New cards

indications of depolarizing neuromuscular blockers (peripherally acting)

rapid intubation

electroshock therapy

28
New cards

effect on competitive neuromuscular blockers when extra ACh is added

reverses the effects of the blocker by increases the odds of ACh binding to receptors instead of the blockers

29
New cards

effect on non-competitive neuromuscular blockers when extra ACh is added

instead of reversing the effects, it actually further desensitizes the receptor so there is an increased blocking effect

30
New cards

when is tubocurarine used? (indication)

surgery adjunct to relax muscle and increase safety anesthetics

31
New cards

tubocurarine _____ cross the BBB

does not

32
New cards

what is the prototype to new non-depolarizing competitive muscle relaxants

tubocurarine

33
New cards

MOA of tubocurarine in small doses

act predominantly at nicotinic receptor sites (blocks post synaptic receptors)

34
New cards

MOA of tubocurarine in high doses

blocks prejunctional Na channels (decreases ACh release)

35
New cards

tubocurarine’s effects can be reversed by..

increasing ACh or giving an AChE inhibitor

36
New cards

tubocurarine can ______ the sympathetic nervous system

suppress

37
New cards

tubocurarine can cause ____ in histamine concentration due to ____

increases; mast cell degranulation

38
New cards

when succinylcholine is contraindicated, which drug can be used instead?

rocuronium

39
New cards

tubocurarine is used for precurarization to prevent ____ due to succinylcholine

postoperative myalgias

40
New cards

tubocurarine is used for precurarization to prevent postopertative myalgias due to _____

succinylcholine

41
New cards

tubocurarine admin

IV due to poor oral bioavailability

42
New cards

ADE of tubocurarine

release of histamine from mast cells which decreases BP and causes bronchospasms

43
New cards

drug interactions of nondepolarizing neuromuscular blockers

aminoglycosides, AChEi, CCBs, halogenated carbon anesthetics

44
New cards

why are aminoglycosides contraindicated with non-depolarizing neuromuscular blockers

they decrease ACh release by competing with Ca

45
New cards

why are CCBS contraindicated with non-depolarizing neuromuscular blockers

increase the actions of non-depolarizing drugs by decreasing ACh release

46
New cards

why are halogenated carbon anesthetics contraindicated with non-depolarizing neuromuscular blockers

they decrease excitability further and decrease BP

47
New cards

noncompetitive neuromuscular depolarizing agents

ACh and succinylcholine

48
New cards

what is desensitization block

when the receptor channels become unresponsive to an agonist which prevents the opening of the channel even when the agonist is bound

49
New cards

indications of succinylcholine

endotracheal intubations

electro shock therapy

adjuvant to anesthesia

50
New cards

ADE of succinylcholine

apnea, fasciculations (twitching), myocyte rupture, myalgia, potassium extravasation, sinus bradycardia, malignant hyperthermia (if have inherited trait)

51
New cards

what is the prototype for depolarizing agents

succinylcholine

52
New cards

succinylcholine is the prototype of…

depolarizing neuromuscular blockers

53
New cards

MOA of succinylcholine (phase I)

cholinergic channels open —> depolarization of membrane —> muscle fasciculation(twitching)

54
New cards

MOA of succinylcholine phase II

end plate eventually repolarizes, succinylcholine continues to occupy the cholinergic receptor to desensitize the end plate

55
New cards

the blocking effects of succinylcholine is augmented by…

AChE inhibitors

56
New cards

therapeutic uses for depolarizing neuromuscular blockers

adjuvant drugs in surgical anesthesia

57
New cards

depolarizing neuromuscular blocking agents duration of action

short bc it is rapidly broken down by plasma cholinesterases

58
New cards

if depolarizing neuromuscular blocking agents are given with _____ it could lead to malignant hyperthermia if they have the inherited trait

halothane

59
New cards

if depolarizing neuromuscular blocking agents are given with halothane it could lead to_____

malignant hyperthermia (inheirted disease)

60
New cards

malignant hyperthermia is only going to occur if…

succinylcholine and halothane are co-admin ANDDDDDD if the person has the inherited autosomal dominant condition

61
New cards

tx for the inherited malignant hyperthermia due to succinylcholine and halothane co-admin

rapid cooling of the body and admin of dantrolene

62
New cards

how does dantrolene work

interferes with EC coupling by decreasing Ca efflux from the SR

63
New cards

depolarizing muscle relaxants depolarize the…

end plate nicotinic receptor

64
New cards

succinylcholine has a ____ duration due to plasma cholinesterases

short

65
New cards

most common side effect of succinylcholine

muscle pain

66
New cards

contraindications of succinylcholine

neuromusclar disease

denervation

immobilization

burns

malignant hyperthermia susceptibility

sepsis

infection

allergy to succinylcholine

67
New cards

succinylcholine drug interactions

inhaled anesthetics, AMGs, CCBs, opioids, lidocaine, pheytoin

68
New cards

succinylcholine interaction with inhaled anesthetics

produce synergistic neuromuscular blockade with these agents.

69
New cards

succinylcholine interaction with AMGs

decreases ACh release from cholinergic nerves to produce additive neuromuscular blockade

70
New cards

succinylcholine interaction with CCBs

may decrease availability of Ca ion for contraction and enhance the effects of neuromuscular blockers

71
New cards

what is the ONLY ganglionic blocker

mecamylamine

72
New cards

mecamylamine class

competitive nicotinic ganglionic blocker

73
New cards

mecamylamine is_____ acting (long or short)

short

74
New cards

mecamylamine must be given ____ bc it is short acting

IV

75
New cards

indication of mecamylamine

lower BP in emergencies

76
New cards

preggo hoes might have less plasma cholinesterases so action of neuromuscular blockers might be _____ (increased or decreased)

increased

77
New cards

preggo hoes might have ______ (more or less) plasma cholinesterases so action of neuromuscular blockers might be increased

less

78
New cards

pts with hepatic or renal issues may have altered elimination of which type of neuromuscular blocker

non-depolarizing

79
New cards

pts with burns are resistant to which type of neuromuscular blocker

non-depolarizing

80
New cards

pts with burns are sensitive to which type of neuromuscular blocker and why

succinylcholine bc it can lead to hyperkalemia

Explore top flashcards